Shortly after rolling out interim data on its COVID-19 antibody hopeful, Eli Lilly last week sent the therapy ahead to the FDA for a potential emergency nod. If the antibody crosses the finish line, Lilly can expect a huge surge in demand—and it’s bringing in a manufacturing partner to help out. Lilly has signed on… Read More »
WASHINGTON (Reuters) – President Donald Trump said on Friday he faced his biggest decision yet with regard to when to re-open the U.S. economy from its coronavirus shutdown and pledged to listen to health experts when making that determination. Speaking at a White House coronavirus briefing, Trump said he would unveil a new advisory group… Read More »
The Food and Drug Administration‘s call on whether to approve Biogen‘s experimental Alzheimer’s drug, aducanumab, will be the “most important decision” the federal regulator will make in 2020, Bernstein analyst Ronny Gal said Friday. When asked if he thought the FDA would approve the drug, Gal said, “Yes.” “[But] you’ve got to be cautious about… Read More »
Digging deeper, the researchers used live imaging to identify specific brain regions that were activated by the mating and threat stimuli. “When we presented both stimuli at the same time and looked at the brain, by and large we saw a response to just the reproductive stimulus, not the fear-inducing stimulus. And even further, the… Read More »
To curb costs in prescription drug spending, clinical decision support can help stop the upward trend of per capita spending that makes cost in this country higher than in any other industrialized nation. Adam Szerencsy, medical director, Ambulatory Informatics, NYU Langone Medical Center, will discuss how the health system was able to reduce its medication… Read More »